Is MIBG a substrate of P-glycoprotein?

被引:0
|
作者
Yasushi Kiyono
Tomoko Yamashita
Hisako Doi
Yuji Kuge
Toshiya Katsura
Ken-Ichi Inui
Hideo Saji
机构
[1] Kyoto University Hospital,Radioisotopes Research Laboratory, Faculty of Medicine
[2] Kyoto University,Department of Patho
[3] Graduate School of Pharmaceutical Sciences,functional Bioanalysis
[4] Kyoto University,Department of Pharmacy, Faculty of Medicine
[5] Kyoto University Hospital,undefined
[6] Kyoto University,undefined
关键词
[; I]MIBG; P-glycoprotein; Transporter; Neuroendocrine tumour; Radionuclide therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:448 / 452
页数:4
相关论文
共 50 条
  • [31] Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein
    Shimizu, M
    Uno, T
    Sugawara, K
    Tateishi, T
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (05) : 538 - 544
  • [32] Is [18F]-pMPPF a P-glycoprotein substrate in human?
    Tournier, N.
    Valette, H.
    Goutal, S.
    Schollhorn, M.
    Saba, W.
    Cisternino, S.
    Scherrmann, J.
    Bottlaender, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S210 - S210
  • [33] Menadione serves as a substrate for P-glycoprotein: implication in chemosensitizing activity
    Seok-Jeong Oh
    Hyo-Kyung Han
    Keon-Wook Kang
    Young-Joo Lee
    Moo-Yeol Lee
    Archives of Pharmacal Research, 2013, 36 : 509 - 516
  • [34] Modeling substrate efflux in human P-glycoprotein at the atomic level
    Gao, Yingjie
    Tang, Yang
    Wei, Caiyan
    Yu, Yongzhen
    Xie, Jiming
    Li, Yaling
    Wei, Siping
    Xing, Juan
    Pan, Xianchao
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025,
  • [35] Midazolam exhibits characteristics of a highly permeable P-glycoprotein substrate
    Tolle-Sander, S
    Rautio, J
    Wring, S
    Polli, JW
    Polli, JE
    PHARMACEUTICAL RESEARCH, 2003, 20 (05) : 757 - 764
  • [36] Midazolam Exhibits Characteristics of a Highly Permeable P-Glycoprotein Substrate
    Sanna Tolle-Sander
    Jarkko Rautio
    Steve Wring
    Joseph W. Polli
    James E. Polli
    Pharmaceutical Research, 2003, 20 : 757 - 764
  • [37] Menadione serves as a substrate for P-glycoprotein: implication in chemosensitizing activity
    Oh, Seok-Jeong
    Han, Hyo-Kyung
    Kang, Keon-Wook
    Lee, Young-Joo
    Lee, Moo-Yeol
    ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (04) : 509 - 516
  • [38] Haloperidol is an inhibitor but not substrate for MDR1/P-glycoprotein
    Iwaki, Koichi
    Sakaeda, Toshiyuki
    Kakumoto, Mikio
    Nakamura, Tsutomu
    Komoto, Chiho
    Okamura, Noboru
    Nishiguchi, Kohshi
    Shiraki, Takashi
    Horinouchi, Masanori
    Okumura, Katsuhiko
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (12) : 1617 - 1622
  • [39] Structural insight into substrate and inhibitor discrimination by human P-glycoprotein
    Alam, Amer
    Kowal, Julia
    Broude, Eugenia
    Roninson, Igor
    Locher, Kaspar P.
    SCIENCE, 2019, 363 (6428) : 753 - +
  • [40] Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein
    Griffin, J
    Fletcher, N
    Clemence, R
    Blanchflower, S
    Brayden, DJ
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2005, 28 (03) : 257 - 265